DOCMORRIS N overview

DocMorris AG / Key word(s): Legal Matter DocMorris AG: ECJ Ruling on advertising for prescription medicines 27-Feb-2025 / 12:36 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Frauenfeld, 27 February 2025 Press release Ad hoc announcement pursuant to Art. 53 LR ECJ Ruling on advertising for prescription medicines The European Court of Justice (ECJ) today answered the questions referred by the German Federal...

DocMorris AG / Key word(s): Development of Sales DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter 21.01.2025 / 06:58 CET/CEST Frauenfeld, 21 January 2025 Press release DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter All business divisions contribute to revenue growth in 2024 OTC revenues increase by 6.7 per cent in 2024 New Rx customers grew fivefold and Rx revenue up 16.6 per cent in the fourth quarter of 2024 TeleClinic...

DocMorris AG / Key word(s): Quarterly / Interim Statement DocMorris accelerates Rx growth 15.10.2024 / 06:58 CET/CEST Frauenfeld, 15 October 2024 Press release DocMorris accelerates Rx growth Rx revenue growth of 12.2 per cent in the third quarter Acceleration to over 25 per cent in the last few weeks Strong increase in new Rx customers OTC growth of 1.9 per cent Pablo Ros Gomez becomes new CTO Closure of the logistics site in Halle (DE) DocMorris' e-prescription business continues to gain...

DocMorris AG / Key word(s): Half Year Results DocMorris grows in the prescription business and invests incrementally in new Rx customers 20-Aug-2024 / 06:58 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Frauenfeld, 20 August 2024 Press release Ad hoc announcement pursuant to Art. 53 LR DocMorris grows in the prescription business and invests incrementally in new Rx customers Sales of prescription medicines...

DocMorris AG / Key word(s): Quarterly / Interim Statement DocMorris with accelerated and significant eRx growth in new customers, market share and revenue 11.07.2024 / 06:58 CET/CEST Frauenfeld, 11 July 2024 Press release DocMorris with accelerated and significant eRx growth in new customers, market share and revenue Tripling of new Rx customers since the introduction of CardLink Doubling and continuous increase in eRx market share since January 2024 17 per cent revenue growth of prescription...

DocMorris AG / Key word(s): Bond DocMorris AG: Early redemption of the 2.75% Convertible Bonds due 2025 23-May-2024 / 06:58 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Frauenfeld, 23 May 2024 Press release Ad hoc announcement pursuant to Art. 53 LR Early redemption of the 2.75% Convertible Bonds due 2025 DocMorris Finance B.V. notifies the bondholders of its convertible bond due in 2025 that it has...

DocMorris AG / Key word(s): Bond DocMorris AG: DocMorris announces results of Tender Offer 14-May-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Please find our press release under the following link: https://ir-corporate.docmorris.com/en/investor-relations/convertible-bonds-2024 End of Inside Information Language: English Company: DocMorris AG Walzmühlestrasse 49 8500 Frauenfeld Switzerland...